BioSpace News Archive

IceCure Medical Reports First Half 2023 Financial & Operational Results: Global Adoption of Cryoablation Technology Gaining Momentum

IceCure Medical Ltd. reported financial results as of and for the six months ended June 30, 2023, as well as operational and recent corporate developments.

August 14, 2023
·
11 min read
Business

Seelos Therapeutics Provides Second Quarter 2023 Clinical Update

Seelos Therapeutics, Inc. (Nasdaq: SEEL) (“Seelos”), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today provided its clinical update for the second quarter ended June 30, 2023.

August 14, 2023
·
5 min read
BioCapital

Caring Cross Featured in White Paper on Strategies for Increasing the Affordability and Accessibility of Genetic Therapies

Caring Cross announced its role in a newly published white paper from the Innovative Genomics Institute, titled “Making Genetic Therapies Affordable and Accessible.”

August 14, 2023
·
3 min read
BioMidwest

GE HealthCare Receives FDA Clearance for Portrait Mobile, A First-Of-Its-Kind, Wireless Monitoring Solution Aiding Early Detection of Patient Deterioration

GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Portrait Mobile wireless and wearable monitoring solution.

August 14, 2023
·
6 min read
FDA

U.S. FDA Approves First Therapeutic Indication for Revance’s DAXXIFY® (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia

U.S. FDA Approves First Therapeutic Indication for Revance’s DAXXIFY ® (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia.

August 14, 2023
·
14 min read
Pharm Country

Koneksa Launches Academic Collaboration Program for Parkinson’s Disease

Koneksa announced the first collaboration in the Koneksa Academic Partnership Program for Parkinson’s Disease to incorporate its Neuroscience Toolkit into research programs.

August 14, 2023
·
3 min read
Business

Sonnet BioTherapeutics Provides Fiscal Year 2023 Third Quarter Business and Earnings Update

Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (“Sonnet” or the “Company”), a biopharmaceutical company developing innovative targeted biologic drugs, announced today its financial results for the three months ended June 30, 2023 and provided a business update.

August 14, 2023
·
10 min read
Business

Panbela Announces Issuance of New Patent in Europe for Claims of a Novel Process for the Production of SBP-101

Panbela Therapeutics, Inc. today announced an Issue Notification for the European patent 2019213664 titled “METHODS FOR PRODUCING (6S,15S)-3,8,13,18- TETRAAZAICOSANE-6,15-DIOL”.

August 14, 2023
·
8 min read
Business

Vaccinex Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Vaccinex, Inc. today announced financial results for the second quarter ended June 30, 2023 and provided a corporate update on progress in key programs.

August 14, 2023
·
15 min read
Business

Allogene Therapeutics Appoints Earl Douglas as General Counsel

Allogene Therapeutics, Inc., a clinical-stage biotechnology company pioneering the development of allogeneic CAR T products for cancer, announced that Earl Douglas has been appointed as General Counsel.

August 14, 2023
·
5 min read